Trials / Completed
CompletedNCT03590275
Observational Retrospective Study of Evaluation of Prognostic Factors in Advanced Pancreatic Cancer Patients Treated With FOLFIRINOX
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 343 (actual)
- Sponsor
- Azienda Ospedaliero, Universitaria Pisana · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The aim of this study is to identify new prognostic factors in patients affected by advanced pancreatic carcinoma treated with first line chemotherapy with FOLFIRINOX regimen. Primary objective is the identification of clinical, laboratory and pathologic factors affecting overall survival of these patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | FOLFIRINOX | Patients treated with first-line FOLFIRINOX (oxaliplatin + irinotecan + lederfolin + 5-fluorouracil) as per clinical practice were included in the study |
Timeline
- Start date
- 2017-10-02
- Primary completion
- 2018-01-18
- Completion
- 2018-06-30
- First posted
- 2018-07-18
- Last updated
- 2018-07-18
Locations
7 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT03590275. Inclusion in this directory is not an endorsement.